HRT Financial’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,667,691
Closed -$5.66M 4344
2026
Q1
$2.94M Buy
+1,667,691
New +$3.62M 0.01% 1334
2025
Q2
Sell
-387,634
Closed -$1.39M 2739
2025
Q1
$1.39M Buy
+387,634
New +$1.56M 0.01% 975
2024
Q1
Sell
-704,433
Closed -$670K 2407
2023
Q4
$670K Buy
+704,433
New +$692K ﹤0.01% 1193
2022
Q4
Sell
-221,809
Closed -$377K 2543
2022
Q3
$377K Buy
+221,809
New +$581K ﹤0.01% 1852
2022
Q2
Sell
-1,687,223
Closed -$5.99M 3020
2022
Q1
$5.99M Buy
1,687,223
+465,027
+38% +$1.35M 0.04% 243
2021
Q4
$4.55M Buy
+1,222,196
New +$7.5M 0.03% 322
2021
Q1
Sell
-89,949
Closed -$1.51M 2742
2020
Q4
$1.51M Buy
+89,949
New +$1M 0.03% 426

Other funds holding CLOV

HRT Financial's CLOV Position: Q2 2026 in Review

HRT Financial sold out of Clover Health Investments (CLOV) in Q2 2026, closing a stake of 1,667,691 shares — an estimated $5.66M sold.

HRT Financial first reported a position in CLOV in Q4 2020 and held it in 7 quarters. The position peaked at $5.99M in Q1 2022. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • HRT Financial reported no remaining Clover Health Investments position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 1,667,691 Clover Health Investments shares in Q2 2026, an estimated $5.66M.
  • HRT Financial first reported a position in Clover Health Investments in Q4 2020 and held it in 7 quarters.
  • HRT Financial's Clover Health Investments position peaked at $5.99M in Q1 2022.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.